1 / 47

Preventing Hospital Acquired Thrombosis

Preventing Hospital Acquired Thrombosis. Simon Noble Peggy Edwards. Preventing HAT. The problem The solution The political agenda What's new…. PE responsible for 10% of deaths in hospital. The problem. Prolonged immobilisation.

ferrol
Download Presentation

Preventing Hospital Acquired Thrombosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards

  2. Preventing HAT • The problem • The solution • The political agenda • What's new….

  3. PE responsible for 10% of deaths in hospital.

  4. The problem

  5. Prolonged immobilisation • post-partum thrombosis known since the middle ages (‘milk leg’) • car-travel related venous thrombosis in the 1930s

  6. During bombing of London in WWII, 6-fold increase of pulmonay embolism in people seeking shelter Reduced by replacing deck chairs by beds (Simpson, Lancet 1940)

  7. Emma Christofferson October 2000 28-year old woman dies from pulmonary embolism shortly after arrival at Heathrow airport, after a 20-hour journey from Australia

  8. (The Mail on Sunday, 17/12/2000)

  9. (Daily Mail, 18/11/2000)

  10. (The Sunday Telegraph, 28/1/2001)

  11. Daily Mail 3/2/01

  12. The Guardian Thursday June 9th 2005

  13. Thromboprophylaxis in hospitalised patients • House of Commons Health Committee 2005

  14. 25,000 Deaths from Hospital Acquired DVT

  15. Thromboprophylaxis in hospitalised patients • House of Commons Health Committee 2005

  16. Thromboprophylaxis in hospitalised patients • House of Commons Health Committee 2005 • CMO 2007 • National Leadership Venous Thromboembolism Strategy • Expert working group • Risk Assessment Tool • NICE Guidelines (due Jan 27th 2010) • SIGN (Draft out to consultation) • CQC: VTE rate to be a KPI

  17. Within Wales • 1000 lives campaign • CMO risk assessment tool • All Wales Guidelines

  18. Circulatory stasis Endothelial Hypercoagulable injury state Virchow’s triad

  19. Simple steps can make a huge change for care • Risk assessment • Thromboprophylaxis to those at risk

  20. Orthopaedic surgery Cancer surgery Neurosurgery Strokes Acute medical illness Thrombosis risk

  21. ENDORSE • 70,000 patients • 358 hospitals • 32 Countries • 51% at risk of VTE • Of those patients at risk of VTE prophylaxis given to • 60% surgical • 40% medical patients (Cohen et al 2008)

  22. Circulatory stasis - Anaesthetic - Bed rest Endothelial injury Hypercoagulable state - Surgery -inflammatory processes Surgery

  23. Surgical prophylaxis In absence of contraindications use a combination of • Pharmacological • LMWH • Fondaparinux • Mechanical • TEDs • Footpumps • IPCs

  24. Barriers to implementation • DVTs! Never see them! • Dangerous stuff that LMWH. • Aspirin is much safer.

  25. General Medical patients • Accounts for 30% all HAT • Highest in • Acute infections • Heart failure • Stroke

  26. Acute medical patients • In absence of contraindications, offer pharmacological prophylaxis to acute medical admissions who are anticipated to be immobile for 3 or more days. • LMWH • UFH • Fondaparinux

  27. Hold on what about TEDs?

  28. No evidence in medical patients. • All supporting studies in surgical patients. • MEDENOX • No additional benefit from adding TEDs

  29. No evidence in medical patients. • All supporting studies in surgical patients. • MEDENOX • No additional benefit from adding TEDs • But absence of evidence does not necessarily mean absence of efficacy?

  30. CLOTS study • Acute stroke patients n=2518 • Full length TEDs vs usual care • DVTE 10% vs 10.6% • No benefit from TEDs (NEJM 2009)

  31. CLOTS study • Acute stroke patients • Full length TEDs vs usual care • No benefit from TEDs • Increased incidence of ulceration, necrosis in intervention group (5% vs 1%)

  32. Any surprises in the new guidelines? • Aspirin is out! • NICE has been developed with BOA so their response will be measured.

  33. Challenges • Detecting rates of HAT • Implementing guidelines • Demonstrating benefit

  34. So how are we going to do it? • 15th December • City Hall • Lifeblood & 1000 Lives joint study day

  35. VTE collaborative • Over 2010 • Three learning sessions • Starting 12th Jan, Llandridnod Wells • Using the model for improvement • We need you to… • Go back tell your Thrombosis Committee • Find your local champions / teams • Engage with your executives to get support

  36. Many thanks See you soon….

More Related